Acutic vs Morningstar Investor (2026)

Who this is for

You pay €249 a year for Morningstar Investor. You use it mostly to check the Star Rating on a stock before you decide, and occasionally to look up the economic moat assessment on a company you already know well. But you find yourself opening three other tabs to get context that Morningstar should have, the navigation confuses you every time, and the tool feels like it was designed for a financial advisor in 2012 — because it largely was.

Acutic was built for investors who want the research depth without the institutional friction. Multi-agent AI analyses candidates in parallel. Every position carries a written thesis and a decision journal. An evaluation module asks, at 30, 90, 180, and 365 days, whether your process held up. It is not an advisor and does not produce per-user transaction instructions — it is a research workspace.

TL;DR. Morningstar is the better tool if you actively research mutual funds, need global coverage on 600,000+ securities including bonds, or rely on the moat framework as a first-pass filter. Acutic is the better tool if you want modern AI research on equities and ETFs, a decision journal, EU-native framing, and a UX that does not make you feel like a compliance officer.

Quick comparison

Pricing sourced from each vendor's public pricing page, May 2026. Acutic pricing is to be announced.

The satisfaction problem is structural

Morningstar's 1.6 / 5 Trustpilot rating is one of the lowest in any software category at this price point. The complaints cluster around three themes: a UX that trained financial advisors find navigable but self-directed retail investors find impenetrable; analyst coverage weighted toward US large-cap equities, leaving EU stocks thin; and a customer support experience that does not justify a $249 annual fee.

This is not a recent decline. Morningstar Investor replaced the legacy Premium tier in April 2025 without meaningfully changing the product experience. The dissatisfaction is structural: a tool designed for professional advisors being sold to retail investors who have different needs, different time budgets, and different tolerance for complexity.

Where Morningstar clearly wins

1. Mutual fund and fixed-income research is unmatched

If your portfolio includes actively managed mutual funds, bond funds, or REITs, there is no retail tool that comes close to Morningstar's depth. Forty years of data, a proprietary Analyst Rating that covers thousands of funds globally, and the most complete fund-fee comparison available anywhere at this price point. Acutic launches with equities and ETFs and does not cover mutual funds — this is a real difference, and Morningstar has it.

2. The economic moat framework is a proven first-pass filter

The wide / narrow / none moat classification — assessing durable competitive advantage — has been refined over twenty years and has predictive validity that independent researchers have confirmed. If you screen heavily by moat before going deeper, that filter is embedded in Morningstar in a way that no newer tool replicates with the same history behind it.

3. Coverage breadth: 600,000+ securities

Bonds, closed-end funds, international small-caps, ADRs — if you research outside the mainstream US equity universe, Morningstar's coverage is the most complete at a retail-accessible price. Acutic covers US equities and ETFs at launch and will expand; for investors with broad cross-asset mandates today, that gap is real.

Where Acutic wins

1. AI research that is actually readable

Morningstar introduced “Mo,” an AI research assistant, in 2025. Based on user reports, it is useful for answering specific data questions but does not produce the kind of structured research narrative that changes how you think about a position. Acutic dispatches a team of specialised LLM agents — quality analyst, fundamentals analyst, technical analyst, news analyst, risk agent — each scoped to its own evidence and output schema. Outputs are Zod-validated, cited, and rendered side-by-side. The result is a research note, not a chatbot response.

2. Built for EU retail investors

Morningstar's analyst team is predominantly US-based. Coverage of European equities — particularly DACH, Nordics, and southern European mid-caps — is thin relative to the same names on US exchanges. Acutic is designed from the ground up for EU investors operating under MiFID II, GDPR, and the EU AI Act. Every AI output is framed as non-personalised research, and the legal architecture is transparent. For an investor in Germany, Austria, or Switzerland, that framing matters.

3. The full workflow, connected

Strategy template → screener → AI research → 7-factor scoring → portfolio tracking → rule-violation alerts → trade journal → evaluation. Morningstar covers a slice of this: excellent data, a portfolio tracker, and a watchlist. For thesis writing, journaling your reasoning, or reviewing how your decisions aged, Morningstar does not help — you need a separate notebook, spreadsheet, or tool.

4. A journal that asks you hard questions later

Every Acutic position carries a written thesis: why you took it, what would change your mind, which rules you agreed to follow. An evaluation module runs at 30, 90, 180, and 365 days and compares what happened against what you wrote down. Over time it builds a personal process-quality record — the part of professional investing that retail tools have universally ignored, and the part that most distinguishes investors who improve from those who repeat the same mistakes.

5. Honest, modern UX

Morningstar's interface was designed for advisors who navigate it daily as part of a managed workflow. For a retail investor who visits weekly, the density and navigation choices feel hostile. Acutic is built around a self-directed retail investor who has limited time and wants clarity, not exhaustiveness.

How to choose

What you might also be looking at

If “Morningstar alternative” brought you here, you may also be evaluating the broader research tool category. We wrote an honest comparison of Acutic vs Seeking Alpha for the crowdsourced-analyst end of the market, and Acutic vs Koyfin for the data-terminal end. Across all of these, one editorial rule applies: every comparison names the place where the other tool is genuinely the better choice. The purpose of candour here is credibility, not concession.